Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants

Hepatology ◽  
1997 ◽  
Vol 26 (2) ◽  
pp. 251-255 ◽  
Author(s):  
F von Weizsäcker ◽  
S Wieland ◽  
J Köck ◽  
W Offensperger ◽  
S Offensperger ◽  
...  
2000 ◽  
Vol 14 (1) ◽  
pp. 57-61 ◽  
Author(s):  
Catherine H Wu ◽  
Lanlan Shen ◽  
George Y Wu

Advantages and disadvantages of viral vectors and nonviral vectors for gene delivery to digestive organs are reviewed. Advances in systems for the introduction of new gene expression are described, including self-deleting retroviral transfer vectors, chimeric viruses and chimeric oligonucleotides. Systems for inhibition of gene expression are discussed, including antisense oligonucleotides, ribozymes and dominant-negative genes.


2001 ◽  
Vol 1 (4) ◽  
pp. 629-639 ◽  
Author(s):  
Charles P Lollo ◽  
Mariusz G Banaszczyk ◽  
Charles R Ill ◽  
Christopher C Coffin ◽  
Michael A Lucas ◽  
...  

2002 ◽  
Vol 123 (6) ◽  
pp. 2154-2155
Author(s):  
Satheesh Nair

2016 ◽  
Vol 54 (12) ◽  
pp. 1343-1404
Author(s):  
B Binder ◽  
A Schuch ◽  
B van Wilgenburg ◽  
A Hoh ◽  
P Klenerman ◽  
...  

2020 ◽  
Vol 18 (7) ◽  
Author(s):  
Tatiana Ghelimici ◽  
Iulianna Lupasco ◽  
Vlada-Tatiana Dumbrava ◽  
Inna Vengher ◽  
Natalia Taran ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document